Spyre Therapeutics Inc (SYRE)

Change in Working Capital

-$8.93M

Quarterly · Period ending: · USD

SYRE logo

SYRE Change in Working Capital

Latest reported-$8.93M
SYRE Quarterly Change in Working Capital (-$485.00K → -$8.93M)
High-resolution chart · PNG

SYRE change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-8,930,000
244,000
-2,265,000
5,940,000
-9,041,000
-568,000
10,798,000
10,351,000
-29,156,000
3,473,000
-1,863,000
-7,951,000
5,972,000
-1,364,000
-1,158,000
1,131,000
-1,067,000
-4,409,000
-1,513,000
495,000
6,390,000
-3,539,000
3,496,000
-1,499,000
54,000
-4,591,000
3,833,000
2,936,000
193,000
142,000
6,173,000
2,277,000
-1,011,000
-238,000
-148,000
-348,000
-75,000
373,000
748,000
-29,000
347,000
384,000
2,593,000
-734,000
-2,922,000
-272,000
-112,000
542,000
81,000
-485,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.